Skip to content

Tania Marcourakis

Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580, Bl. 13B, São Paulo, SP, 05508-000, Brazil.

2 papers in the library · 3 citations · publishing 2025

Papers

Ketamine-Ethanol Combination Decreases Reduced Glutathione Levels and Activates both Intrinsic and Extrinsic Apoptotic Pathways Prior to Neuronal Death in SH-SY5Y Cells.

Neurotoxicity research June 7, 2025 Felype Valentim Duarte Castelhano, Carolina Aparecida de Faria Almeida, Giulia de Assis Braz et al. 3 citations

Combining ketamine with ethanol triggers greater nerve cell death than either drug alone, acting through oxidative stress and two programmed-cell-death pathways. In human neuroblastoma cells, the lowest observed adverse-effect levels were 1 mM ketamine and 100 mM ethanol. After 48 hours, the combination produced a possible synergistic increase in late apoptotic cells. Glutathione levels fell within 6 hours, and glutathione-peroxidase activity rose in all groups. Only the combination increased glutathione reductase and glutathione S-transferase activities after 3 hours, along with elevated caspase-8 and Bax expression, signaling both extrinsic and intrinsic apoptosis. The findings suggest heightened neuronal damage risk from combined use, though limitations include enzyme-activity variability, reduced sample size for some markers, and use of an immortalized cell line.

Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl/6 mice.

Psychopharmacology October 31, 2025 Vítor Bruno, Lídia Emmanuela Wiazowski Spelta, Matheus Lujan Pereira et al.

Ayahuasca, a brew containing DMT and β-carbolines used in indigenous rituals, has shown potential for treating substance use disorders. In C57Bl/6 mice, ayahuasca at a high dose (15 mg DMT/kg) induced rewarding effects, but these were weaker than those of cocaine. When mice were conditioned with cocaine and later treated with ayahuasca (12.5 or 15 mg DMT/kg), the brew prevented the reinstatement of cocaine-induced conditioned place preference after a cocaine challenge. The findings suggest ayahuasca may have therapeutic value for cocaine use disorder by reducing relapse to drug-seeking behavior.